A. D. den Boer

发表

The role of CD40 in peripheral T cell tolerance and immunity

R. Offringa, C. Melief, R. Toes, 2000, Journal of Molecular Medicine.

CD40 stimulation leads to effective therapy of CD40− tumors through induction of strong systemic cytotoxic T lymphocyte immunity

R. Offringa, C. Melief, J. Medema, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Successful immunotherapy of an intraocular tumor in mice.

W. Kast, C. Melief, A. Boer, 1999, Cancer research.

CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.

R. Offringa, C. Melief, R. Toes, 2005, Cancer research.

Angelman syndrome without detectable chromosome 15q11-13 anomaly: clinical study of familial and isolated cases.

R. Hennekam, O. Brouwer, L. Laan, 1998, American journal of medical genetics.

The Tumoricidal Activity of Memory CD8+ T Cells Is Hampered by Persistent Systemic Antigen, but Full Functional Capacity Is Regained in an Antigen-Free Environment1

R. Offringa, C. Melief, R. Toes, 2004, The Journal of Immunology.

Angelman syndrome in adulthood.

R. Hennekam, O. Brouwer, L. Laan, 1996, American journal of medical genetics.

In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway1

R. Offringa, C. Melief, R. Toes, 2002, The Journal of Immunology.

Rejection of Intraocular Tumors by CD4+ T Cells Without Induction of Phthisis1

C. Melief, J. Medema, J. Laman, 2001, The Journal of Immunology.

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Rob J. de Boer, P. Friedl, C. Figdor, 2021, Nature Communications.

Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.

R. Hennekam, E. Kalkhoven, H. Teunissen, 2003, Human molecular genetics.

Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT

E. Feskens, J. Tuomilehto, J. Eriksson, 2013, PloS one.

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication1

R. Offringa, C. Melief, H. Dumortier, 2004, The Journal of Immunology.

Cancer cell elimination by cytotoxic T cell cooperation and additive damage

P. Friedl, C. Figdor, R. D. de Boer, 2020 .

Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.

E. Feskens, E. Blaak, E. Corpeleijn, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.